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Patellofemoral  arthroplasty  remains  controversial,  primarily  due  to  the  high  failure  rates  reported  with
early implants.  Several  case  series  have  been  published  over  the  years,  which  describe  the  results  with
various  ﬁrst- and  second-generation  implants.  The  purpose  of  this  work  was  to summarize  results
published  up  to  now  and  identify  common  themes  for implants,  surgical  techniques,  and  indications.
First-generation  resurfacing  implants  had  relatively  high  failure  rates  in  the medium  term.  Second-
generation  implants,  with  femoral  cuts  based  on  TKA  designs,  have  yielded  more  promising  medium-term
results.  The  surgical  indications  are  quite  speciﬁc  and must  be chosen  carefully  to minimize  poor  results.
Short-term  complications  are generally  related  to  patellar  maltracking,  while  long-term  complications
are  generally  related  to  progression  of  osteoarthritis  in the tibiofemoral  joint.  Implant  loosening  and
polyethylene  wear  are  rare.  Overall,  recent  improvements  in implant  design  and  surgical  techniques  have
resulted in  better  short-  and  medium-term  results.  But  more  work  is  required  to assess  the  long-term
outcomes  of  modern  implant  designs.. Introduction
Isolated patellofemoral arthritis is relatively rare [1] and the best
urgical treatment is highly debated. Patellofemoral arthroplasty
PFA) is an increasingly popular option [2,3], but it is controversial
ecause of inconsistent results [4,5] and the relatively high failure
ate found in some studies [6–8].
This article will provide detailed information on the various
ypes of patellofemoral (PF) implants available along with indica-
ions and surgical techniques. Clinical results and complications
eported with different implant designs will also be reviewed.
inally, the outcome of revising these patellofemoral implants will
e discussed.
. History and design considerations [9]
.1. History
MacKeever ﬁrst proposed a vitallium patellar resurfacing
mplant in 1955, which, despite good initial results [10,11], was
uickly abandoned because of excessive wear in the trochlear
roove. Patellofemoral arthroplasty had a rebirth in the 1970s
hen the Richards prosthesis (Smith-Nephew-RichardsTM) was
ntroduced [12].
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2.2. Implant design
Patellofemoral implants attempt to reproduce the complex
kinetics of patellofemoral joint during knee ﬂexion, allowing patel-
lar movements in the sagittal, axial, and coronal planes. More highly
constrained trochlea designs produce less natural patellar motion;
this may  contribute to increased loads on the PF joint and pre-
mature polyethylene wear. Conversely, a less constrained implant
design allows more degrees of freedom but may increase the risk
of patellar subluxation and dislocation.
2.2.1. Implant types
The two main types of patellofemoral implants are based on the
trochlea preparation method: resurfacing implants and anterior cut
implants:
• resurfacing (ﬁrst-generation) implants (Fig. 1) simply replace
worn cartilage without signiﬁcantly changing the shape of the
subchondral bone (inlay technique). Since they are embedded in
subchondral bone, their positioning depends on the anatomy of
the native trochlea (Fig. 2). Some implants are asymmetric, such
as the Spherocentric [13], LCS [14] and Autocentric. Others are
symmetric, such as the Richards III [12] and Lubinus [15];
• anterior cut (second-generation) implants (Fig. 3) use the same
anterior femoral cuts as total knee arthroplasty (TKA); these
implants are often designed based on the femoral trochlear
groove of TKA implants. Instead of replacing only the cartilage lost
due to wear, they completely replace the anterior compartment
of the knee (Figs. 4–6).
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Fig. 1. Resurfacing type implants: Richards IIITM (A), Spheroce
Fig. 2. Intraoperative view of a resurfacing patellofemoral implant; the shape of the
subchondral bone is not altered since the implant only replaces worn cartilage.ntricTM (B), AutocentricTM (C), LCSTM (D), LubinusTM (E).
Some of these implants have an asymmetric trochlea such as
the HermesTM, VanguardTM, JourneyCompetitorTM, LeicesterTM or
GenderTM. Others are symmetric such as the AvonTM [16]. The
femoral implant must be aligned in valgus to match the mechanical
axis of the lower limb instead of the axis of the native trochlea.
2.3. Implant geometry
Patellofemoral implants can also be classiﬁed using speciﬁc
geometry features that determine joint biomechanics.
2.3.1. Trochlear component
When the trochlear component is asymmetric, an elevated lat-
eral ﬂange is used to resist lateral forces exerted by the quadriceps
[17].
The point at which the patellar button engages the trochlea is
determined by the sagittal radius of curvature of the trochlea and
the amount of anterior femoral coverage [18]. In implants with less
trochlear coverage, the amount of ﬂexion or extension in which
the implant is placed can signiﬁcantly affect patellar tracking. But
in some models, femoral coverage extends proximally beyond the
native trochlea, ensuring contact with the patellar button even in
full extension.
Similarly, implants with extended distal coverage can pre-
vent contact between the native articular cartilage of the femoral
condyles and the patellar button in deep ﬂexion.
The shape of the trochlear groove also varies greatly between
models [19], ranging from deep, highly constrained trochlea such
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Fig. 3. Anterior cut type implants: HermesTM (A), VanguardTM (B), JourneyCompetitorTM (C), GenderTM (D), AvonTM (E).
Fig. 4. Intraoperative view of an anterior cut type implant. The anterior cut here is
the same one performed during total knee arthroplasty.
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AvonTM).
s the Richards IIITM to more open, unconstrained designs such as
he AvonTM.
.3.2. Patellar component
The patellar button can be shaped as a dome, have facets and be
ither symmetric or asymmetric. Spherical dome designs theoret-
cally allow automatic self-centring of the patella on the trochlea,
bsorbing any residual tilt. If revision is required, these modelsFig. 6. Intraoperative view of an anterior cut patellofemoral implant (AvonTM); the
trochlear component completely replaces the native trochlea.
can also generally match the trochlear shape of a subsequent TKA,
eliminating the need to change the patellar button [20].
3. Indications
As with any unicompartmental knee replacement, the success of
patellofemoral arthroplasty is highly dependent on patient selec-
tion [3,12,21,22]. This procedure can be indicated in patients with
isolated primary or post-traumatic patellofemoral osteoarthritis or
in patients with patellofemoral arthritis associated with trochlear
dysplasia [23] and patellar subluxation [24] (Fig. 7).
There are several contraindications to PF arthroplasty: chon-
drocalcinosis, evidence of signiﬁcant osteoarthritis or pain in
the medial or lateral tibiofemoral compartments [3], obvious
tibiofemoral alignment defect. Inﬂammatory joint disease is an
absolute contraindication because several joints are affected, not
only the patellofemoral one.
Radiology evaluation must consist at least of weight-bearing
AP and lateral views of the involved knee and skyline view with
knee ﬂexed at 45 degrees. Weight-bearing measurements are used
to determine relative femur and tibia alignment on X-rays. CT
arthrography is sometimes used to determine the condition of the
cartilage. Bone scintigraphy or even SPECT/CT imaging [25] can also
be performed during the preoperative evaluation to help determine
where the pain is coming from.There is insufﬁcient information to determine whether chronic
anterior laxity is deleterious to the function and longevity of the PF
arthroplasty. Patient age should also be considered. Some authors
advocate using this procedure only in patients under 60 years of age
S38 S. Lustig / Orthopaedics & Traumatology: Surgery & Research 100 (2014) S35–S43
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difﬁcult to measure using the Tibial Tuberosity–Trochlear Groove
distance because of the arthritic changes in the trochlea) but in
some cases are only ﬁnalized at the end of the procedure when the
patella is still not tracking normally.ig. 7. Patellofemoral arthroplasty performed for patellofemoral OA secondary to
ysplasia seems to lead to better results than arthroplasty performed for primary
A, as long as the malalignment of the extensor mechanism is corrected.
26], but there is currently no evidence demonstrating any impact
f patient age on outcomes.
Better clinical outcomes have been reported in patients with
steoarthritis secondary to trochlear dysplasia rather than other
auses [2,27–29]. These studies concluded that trochlear dysplasia
as the ideal PFA indication. Conversely, a recent report on the
3-year results of a series of 185 consecutive Richards II implants
ound no relationship between the initial diagnosis, gender or age
t surgery on the revision rate. Obesity with a BMI  > 30 kg/m2 leads
o a poor prognosis.
In theory, preoperative patella infera, often found in osteoarthri-
is secondary to patella fracture, should have a negative effect on
FA outcomes. Some consider patella infera to be a contraindica-
ion for PFA [30], although there is no objective data available on
his topic.
. Surgical technique
The surgical technique differs between a resurfacing implant
ersus and an anterior cut implant [9].
The ﬁrst step in the implantation of a resurfacing implant con-
ists of using trial components to determine the size of the femoral
omponent. The goal is to provide coverage from the superior edge
f the trochlea to the anterior edge of the intercondylar notch, and
o cover most of the lateral border of the native trochlea. It can only
dapt to the orientation of the native trochlea, while avoiding any
nternal rotation. The trochlear recess is prepared without any true
nstrumentation. The superior edge of the trochlea is embedded
nto the anterior cortex, while making sure the transition between
he trochlea and condyles is smooth. The patella is prepared using
tandard techniques.
We  prefer working with anterior cut implants because the
mplantation technique is more reproducible and speciﬁc instru-
entation is available. These implants now dominate the global
arket. The incision must be long enough to correctly positioning
he cutting blocks and guides; in most cases the patella is dislocated
aterally.
As a general rule, the femur is prepared using anterior cutting
uides placed on an intramedullary guide (Fig. 8), while making
ure not to damage the anterior cortex. At this point, the surgeon
an either:perform an “anatomical” anterior cut, parallel to the chosen ref-
erence plane (posterior condylar axis, etc.) and then recentre
the patella by freeing up the lateral retinaculum; tibial tubercle
osteotomy can also be performed if needed;Fig. 8. Intraoperative view of an anterior cutting guide placed on an intramedullary
guide.
• perform a “functional” anterior cut, with more external rotation
relative to the patellar plane; this can be combined with lateral
translation of the femoral component to avoid having to touch
the extensor mechanism to recentre the patella.
With newer implants, the anterior cut and condyles are joined
by reaming (Fig. 9). Then holes are drilled for the anchoring pegs.
The trial implant is then impacted to ensure no ACL impingement
and no step-off with the condylar cartilage. The patella itself is pre-
pared as it would be for any total knee arthroplasty. The patellar
button can be medialized to prevent initial subluxation.
In cases of subluxation or signiﬁcant patellar tilt, medialization
of the tibial tubercle (with or without release of the lateral retinac-
ulum and/or lateral facetectomy) is a viable option because the PF
implant itself will not be able to stabilize the patella if a severe align-
ment defect exists. In this case, a lateral approach in combination
with tibial tubercle osteotomy may  be better since the extensor
mechanism alignment can be corrected at the end of the proce-
dure. In cases of severe patella alta, the tibial tubercle could also be
moved distally, especially if the patella does not articulate with the
trochlea in full extension.
These procedures can be planned based on the preoperative
evaluation (even if the lateral position of the tibial tubercle is oftenFig. 9. Reaming guide used to prepare the junction between the anterior cut and
condyles (GenderTM).
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. Results
The outcomes for PF implants are quite variable, likely because
f the evolution in implant design, patient selection and surgical
echniques [3].
.1. Scoring systems
Published studies use a variety of different scoring systems,
aking comparisons between studies difﬁcult. While scores such
s the Knee Society [31] or Oxford Group are very useful for eval-
ating knee osteoarthritis treatments, speciﬁc tools are needed to
valuate the outcomes of PFA treatments.
Several score systems have been proposed including the Bris-
ol score [3], Bartlett score [32], Fulkerson score [33], and Lonner
core [5]. However, none of these are currently validated. After
omparing various clinical scoring systems, Fithian and Paxton [34]
etermined that the Short-Form 36 (SF 36) and Knee Injury and
steoarthritis Outcome Score (KOOS) are the most suitable for post-
perative evaluation of PF implants.
.2. Results of different implants
.2.1. RichardsTM (Smith & Nephew)
A key feature of this implant is its highly constrained (deep)
rochlea. The ﬁrst publication in 1979 by Blazina et al. [12] included
7 Richards I and II implants and reported a 16% revision rate after
wo years of follow-up. Several studies looking into the short- or
edium-term results of this implant [21,35,36], found a high num-
er of early reoperations for instability or impingement because of
oor positioning. Case series with longer follow-up have also been
ublished. The survival was 75% at 11 years [37]; satisfactory results
ere achieved in 86% of cases after 15–21 years of follow-up [38];
9% survival has been reported after 20 years [24].
In every series, the main reason for revision was progression
f the tibiofemoral arthritis. However, reoperation of soft tissues
as also required early on in a large number of patients due to
atellofemoral complications such as patellar catching, subluxation
nd persistent pain. These results were consistent with Lonner’s
nalysis [20], who found that designs where the patella is highly-
onstrained due to a deep trochlear groove are less able to mitigate
oor patellar tracking. These implants require the patient to have
ood alignment a priori or require an additional realignment pro-
edure during implantation.
.2.2. LubinusTM (Waldemar Link)
The follow-up is fairly short in all the published series. Tauro
t al. [15] reported implant survival of 65% at 8-year follow-up, but
nly 45% had good or excellent results. The most common cause of
evision was poor patellar tracking (75%). Smith et al. [39] reviewed
5 patients with a mean age of 72 years with a follow-up of four
ears. The reoperation rate was 42%, while 11% of patients were
onverted to TKA. Board et al. [40] also reported mixed results after
 19-month follow-up of 17 patients. Only 53% of patients had good
o very good results and the reoperation rate was 35% (including
4% revised to TKA). They concluded that the implant was very
oorly tolerated and advised against using it. Also, several stud-
es have noted the LubinusTM implant to be prone to revision for
atellar tracking problems [6,20].
In summary, results with the LubinusTM implant have been
isappointing, with high complication rates and early revisions
eported in all published studies with this implant..2.3. AutocentricTM (Depuy)
Published results with the AutocentricTM implant are also
nconsistent. Some studies have found satisfactory medium-termgery & Research 100 (2014) S35–S43 S39
results (84% patient satisfaction, 66 cases, 2-10 year follow-
up) [28]. When reviewed after an average of 16.2 years (range
12–20 years), 14 knees had been revised to TKA for progres-
sion of tibiofemoral osteoarthritis. Patients treated for primary
patellofemoral osteoarthritis were more likely to have undergone
revision than those treated for trochlear dysplasia. The survival rate
at 16 years was  58%.
Disappointing results have been reported after an average of
4.8-years follow-up (range 2–11 years) in 24 patients having pri-
mary patellofemoral osteoarthritis [41]. The reoperation rate was
87.5%, while 29% had been converted to TKA because of tibiofemoral
osteoarthritis progression or patellar maltracking. In another study,
the survival rate was 62% at 10 years [27]. Overall, the reoperation
rate is relatively high, although the main outcome predictor is the
aetiology of the PF osteoarthritis. Arthritis secondary to trochlear
dysplasia seems to be better indicated for the AutocentricTM
implant than primary or post-traumatic osteoarthritis [28].
5.2.4. LCSTM (Depuy)
This metal-backed, mobile-bearing patellar component is com-
patible with both the trochlear component in PFA and the femoral
component of the TKA in the same product line. The drawback of
this design is that the patellar button must be changed if a TKA
implant from another product line is used. Also, some authors have
reported dislocation [42] and polyethylene separation [7] with this
implant.
The ﬁrst published results with this implant found 93% good
and excellent results reported after 4.5 years of follow-up in
16 cases [14]. But other studies subsequently reported results
that were not as good. Arumilli et al. [43] reported failure with
the cemented, metal-backed patellar component due to excessive
polyethylene wear, metal–metal contact, and fracture/dislocation
of the polyethylene in the ﬁrst two years after implantation. Char-
alambous et al. found 17 revisions (33.3%), consisting of 16 TKA
and one patellar button, with a relatively short follow-up of two
years [44]. They also described three cases of extensive metallosis
and several cases where polyethylene patella had been rendered
immobile because of ﬁbrosis around the implant. Because of the
high complication rate and early failures, marketing of the LCSTM
implant was discontinued in 2009.
5.2.5. AvonTM (Stryker)
This “second-generation” implant uses an anterior cut similar
to most TKA systems. Lonner et al. [20] were the ﬁrst to report on
their experience with this implant. The early complication rate was
less than with the LubinusTM implant.
Since then, medium-term (average of seven years follow-up in
published studies) outcomes have been reported by several groups.
Starks et al. [45] also reported 100% good and excellent results after
two years but 22% of patients had radiological signs of tibiofemoral
osteoarthritis. Leadbetter et al. [46] completed a multicentre study
of 79 knees followed for three years. They noted 84% good and
excellent results. Ninety percent of patients reported not having
any knee pain during activities of daily living. In the Ackroyd et al.
study [47], the survival rate at ﬁve years was 95.8% with satis-
factory results in 80% of cases. The main complication was  the
progression of tibiofemoral osteoarthritis (28% of cases). In the Odu-
menya et al. study [18], 100% of implants were still in place ﬁve
years following implantation. However, patellar tilt was found in
16% of cases, lateral patellar subluxation in 14% and progression of
tibiofemoral osteoarthritis in 22%. Nicol et al. [29] noted a revision
rate of 14% after an average follow-up of 7.1 years, primarily due
to progression of tibiofemoral osteoarthritis. They noted excellent
results in patients treated for arthritis secondary to trochlear dys-
plasia. Finally, seven-year survival was  82% in the Mont et al. study
[48]; there were three cases of aseptic loosening and two cases of
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rogression of tibiofemoral osteoarthritis less than one year after
mplantation.
In general, published results with the AvonTM are encouraging,
ut longer follow-up is needed to determine whether these results
old up over time.
. Complications
.1. Early postoperative complications
The rate of early postoperative complications is higher for
atellofemoral arthroplasty than total knee arthroplasty [49]. Early
ostoperative complications include persistent anterior knee pain,
atellar catching or snapping, and extensor mechanism rupture.
Poor positioning of the femoral component can be further com-
licated by patellar maltracking or even patellar instability [47].
adeyne et al. [27] showed that placing the femoral component in
nternal rotation was associated with higher reoperation rates. Mis-
lignment of the extensor mechanism and an over-sized femoral
omponent can also result in anterior knee pain (Figs. 8 and 9). Both
f these complications bring about high rates of early revision.
Peripatellar pain may  be an early consequence of “overstufﬁng”
he patellofemoral joint (Fig. 10), which occurs when the implant
sed is thicker than the amount of bone and cartilage resected. A
ecent study found that patients with the worst functional results
ad greater increase in patellar thickness following surgery [50].
Lonner et al. [3] also reported that postoperative instability
ften results from inadequate soft tissue release. Similarly, failing to
ddress signiﬁcant patella alta by moving the tibial tubercle distally
lso increases the risk of postoperative patellar instability.
The incidence of many early complications has decreased with
he introduction of newer patellofemoral arthroplasty designs
2,30]. For example, Ackroyd et al. [47] in a series of 306 patients
reated with the AvonTM noted only a 4% incidence of anterior pain,
ig. 10. Malpositioning of the trochlear component must be avoided at all costs. The
ateral X-rays showing a trochlear implant placed too far forward in ﬂexion, leading
o  anterior impingement and early post-operative pain.rgery & Research 100 (2014) S35–S43
5% incidence of complications related to the extensor mechanism
and 1.6% rate of arthroﬁbrosis.
6.2. Late complications
6.2.1. Progression of tibiofemoral osteoarthritis
Because newer implant designs have reduced the number of
complications due to patellar maltracking, the main cause of revi-
sion surgery is now progression of tibiofemoral osteoarthritis. The
reported revision rate for tibiofemoral osteoarthritis is up to 22%
after 5 to 15 years of follow-up [36,38].
In a study with 306 AvonTM implants, Ackroyd et al. [47] found
that progression of tibiofemoral osteoarthritis was  the most com-
mon  late complication. This complication could not be predicted by
the functional results or pain control achieved by the PF implant in
the ﬁrst two years after surgery.
Progression of tibiofemoral osteoarthritis is more common in
patients operated for primary patellofemoral osteoarthritis. Nicol
et al. [29] in a prospective study of 103 AvonTM implants reported a
12% revision rate due to progression of tibiofemoral osteoarthritis
after 7.1 years. The average time to revision was  55 months. The rate
among patients treated for primary osteoarthritis was  17%, while it
was 0% in patients treated for osteoarthritis secondary to trochlear
dysplasia. The progression of tibiofemoral osteoarthritis after PFA
for primary osteoarthritis is even more prevalent if there is a pre-
existing tibiofemoral alignment defect when the PFA is performed.
6.2.2. Loosening
Loosening is a relatively rare complication. Lonner et al. [26]
reported that fewer than 0.5% of revisions were due to loosening
after a seven-year follow-up. Most of the reported cases involved
cementless implants [51]. Gadeyne et al. [27] found a 24% failure
rate in a study of 43 AutocentricTM implants after 74 months. While
2 of the 11 revisions were for loosening, each was associated with
improper femoral component positioning. Kooijman et al. found
only a 2% loosening rate after a follow-up of 15.6 years [38].
7. PFA revision
Few studies have looked speciﬁcally at PFA revisions. In 2006,
Lonner et al. [52] described 12 PFA revisions in 10 patients. Ten
knees had been operated for osteoarthritis secondary to trochlear
dysplasia and two  for post-traumatic osteoarthritis. The PFA and
TKA procedures were separated by four years on average. The
indication for revision was  tibiofemoral OA in six cases, patellar
instability in three cases and a combination of both in three cases.
In all cases, a posterior-stabilized TKA was used. The implanted
patellar buttons were dome-shaped polyethylene implants that
were well-positioned, well-ﬁxed, showed little wear; the trochlear
congruence and tracking in the femoral component were deemed
satisfactory at the end of the procedure. In all cases, these patel-
lar implants could have been preserved. A femoral stem was not
needed and the bone defect created when the femoral component
was removed was mostly negated through the anterior and dis-
tal femoral TKA cuts. With a follow-up of 3.1 years after TKA, the
knee scores and function had clearly improved. Flexion range of
motion was  satisfactory, but required mobilization under general
anaesthesia in one case and arthroscopy in another.
Van Jonbergen et al. [53] compared the outcomes of 14 PFA to
TKA conversions with those of a control group of 14 primary TKA
cases. The knee and function scores and WOMAC  were comparable,
but mobilization was  required in three cases of PFA to TKA conver-
sion. The authors concluded that PFA has a negative effect on the
results of a future TKA.
In a 2008 study, the LubinusTM PFA was replaced by the AvonTM
PFA in 14 cases [6]. The average time between the initial PFA
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nd revision was 67 months (range 7–128). The reasons for revi-
ion were patellar maltracking (8 cases), polyethylene wear with
ynovitis (9 cases), wrong position of the trochlea (3 cases) or
atella (2 cases) and excessively large implant (1 case). In 11
ases, the two components were changed. With an average follow-
p of 60 months, the results were satisfactory, but tibiofemoral
A was present in ﬁve patients, with two of them needing TKA.
his series raises the possibility of revising a PFA implant with a
ifferent PFA implant instead of performing TKA, although the indi-
ations are limited (no tibiofemoral OA, more suitable PFA revision
mplant design, sufﬁcient bone in the trochlea, patient too young for
KA).
able 1
ublished clinical results of patellofemoral arthroplasty.
Study Year Implant n 
Blazina et al. [12] 1979 Richards I/II 57
Arciero and Toomey [21] 1988 Richards II CFS-Wright 25
Cartier et al. [35] 1990 Richards II/III 72
Argenson et al. [51] 1995 Autocentric 66
Krajca-Radcliffe and Coker [36] 1996 Richards I/II 16
Mertl  et al. [13] 1997 Spherocentric 51
Arnbjörnsson and Ryd [61] 1998 Blazina
Lubinus
Richards II
Other
113
de  Cloedt et al. [62] 1999 Autocentric 45
de  Winter et al. [63] 2001 Richards II 26
Tauro  et al. [15] 2001 Lubinus 62
Smith  et al. [39] 2002 Lubinus 45
Kooijman et al. [38] 2003 Richards II 45
Board  et al. [40] 2004 Lubinus 17
Merchant [14] 2005 LCS 16
Lonner [20] 2004 Lubinus 30
Lonner [20] 2004 Avon 25
Argenson et al. [28] 2005 Autocentric 66
Ackroyd and Chir [16] 2005 Avon 306
Cartier et al. [37] 2005 Richards III 79
Sisto  and Sarin [57] 2006 Kinamatch 25
Cossey and Spriggins [54] 2006 Avon (navigation) 4
Nicol  et al. [29] 2006 Avon 103
Ackroyd et al. [47] 2007 Avon 109
Gadeyne et al. [27] 2008 Autocentric 43
Mohammed et al. [64] 2008 Avon
Lubinus
Femoro Patella Vialla
101
Butler  and Shannon [59] 2009 Performa 22
Leadbetter et al. [2] 2009 Avon 79
Starks  et al. [45] 2009 Avon 37
Van  Wagenberg et al. [41] 2009 Autocentric 24
Van  Jonbergen et al. [24] 2010 Richard II 185
Odumenya et al. [18] 2010 Avon 50
Charalambous et al. [44] 2011 LCS 51
Sarda  et al. [65] 2011 Avon 44
Mont  et al. [48] 2012 Avon 43
Beitzel et al. [66] 2013 Journey 22gery & Research 100 (2014) S35–S43 S41
8. Future directions
Published studies have revealed that outcomes of PFA are highly
dependent on implant design, surgical technique and indications.
Since greatly improved implants and instrumentation sets are now
available, we  can only hope that future developments will further
improve the outcomes of PFA.8.1. Surgical navigation
It is easy to imagine that computer assisted surgery could
improve the reproducibility of positioning in PFA. Cossey et al. [54]
Age
(years)
Follow-up
(years)
Revision
rate (%)
Good & excellent
results
 39 2 35 N/A
 62 5.3 28 72
 65 4 7 85
 57 5.5 15 84
 64 5.8 6 88
 60.5 3 6 82
 56 7 22 75
 51 6 18 63
 59 11 19 76
 66 7.5 28 45
 72 4 19 64
 50 17 22 86
 66 1.5 35 53
 47 4.5 0 94
 38 4 33 84
 44 0.5 0 96
 57 16.2 42 N/A
 62 N/A 3.6 N/A
 60 10 25 77
 45 6 0 100
 52 1 0 100
 68 7.1 14 N/A
 68 5.2 15 80
 67 6 24 72
 57 4 4 72
 48.6 5 14 N/A
 58 3 16 84
 66 2 0 86
 64 4.8 29 30
 52 13.3 25 N/A
 66 5.3 4 N/A
 64 2 33 33
 61.7 4.5 5 85
 49 7 12 N/A
 46.4 2 0 N/A
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escribed one-year results of AvonTM implants implanted with a
avigation system without imaging. All patients had good or excel-
ent results with no early failures or post-operative instability.
Robot-assisted surgery also holds promise for improving the
eproducibility of implant positioning [55,56]. These systems
equire preoperative CT scanning to plan the ideal implant posi-
ion. A robotic arm then guides the bone cuts and helps the surgeon
lace the implant in the predeﬁned position.
.2. Custom-made implants
New technology has enabled the development of custom
mplants, which reproduce the radius of curvature of the
atellofemoral joint based on three-dimensional reconstructions.
hese optimize bone coverage without placing excessive loads on
he patella. Encouraging results have been reported in a series of
5 custom-made implants (Kinamed Custom ImplantsTM). With an
verage follow-up of 73 months, all patients had good or excel-
ent results and there were no revisions [57,58]. Butler et al. [59]
lso reported good results in 22 patients with custom implants
Biomet® Performa Prosthesis) after ﬁve years, but two cases of
tiffness had to be treated arthroscopic.
.3. Bicompartmental arthroplasty
The combination of medial unicompartmental arthroplasty and
atellofemoral arthroplasty is an option that has recently gar-
ered renewed interest because of good long-term results [56,60].
his option extends PFA indications to young, active patients with
icompartmental OA or raises the possibility of adding a unicom-
artmental knee arthroplasty in cases where the OA progresses
fter PFA.
Results of the implants featured in the greatest number of pub-
ications worldwide are summarized in Table 1.
. Conclusion
Recent series demonstrate that better and more modern
atellofemoral implant designs and surgical techniques have
roduced satisfactory results in the short and medium term
18,29,47,48]. However, indications are limited and past failures
ust not be forgotten. Long-term studies are needed to determine
f these positive results are sustainable.
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